Kriya Therapeutics
- Health & Biotech
- Durham, NC, US
- Founded 2019
- Private
- kriyatx.com
Clinical-stage biopharma developing gene therapies for common chronic diseases such as geographic atrophy, thyroid eye disease and type 1 diabetes.
$320MEquity raised in 2025–20262025 $320M · 2026 — · 1 equity round
$320MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. Kriya Therapeutics was founded in 2019 and raised before 10 Sep 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series DAmount$320MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 5
- Patient Square Capital1
- Premji Invest1
- Narya Capital
- Peter Thiel
- The T1D Fund
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
EnvedaHealth · $461M in 2025–2026Shared: Premji InvestRhoda AIRobotics · $450M in 2025–2026Shared: Premji InvestDatabricksEnterprise · $10B in 2025–2026Shared: Premji InvestBasetenAI Infra · $2B in 2025–2026Shared: Premji InvestRunwayAI Apps · $623M in 2025–2026Shared: Premji InvestKreditBeeFintech · $280M in 2025–2026Shared: Premji Invest
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Kriya Therapeutics and its logo are trademarks of their owners, used here for identification only.
